nir-vana innovation network

Recently, bone graft materials have being used to reconstruct the alveolar bone which plays an important role for dental implant treatment. Various bone graft materials are introduced in the market such as autogenous bone, allogeneic bone, and heterogenous bone. However, these bone graft materials show various adverse effects and become huge financial burden, and thereby requiring a new synthetic bone graft material. A Korean company, which produces dental materials and devices, has developed a new type of synthetic bone graft, consist of OCP, a precursor of bone mineral apatite (HA, Hydroxy apatite). This new product contains a large amount of OCP and shows excellent safety, fast new bone formation, high resorption/porosity, and good manipulation and easy use. Although synthetic bone graft materials have no risk of immune rejection or infection, these are not of high demand in the traditional market because the components of HA(Hydroxy apatite) and beta-TCP(Tricalcium Phosphate) don’t effectively help to regenerate new bone. But this Korean company’s product shows more efficient and competent in new bone formation due to its OCP component that is closer to human bone than HA and beta-TCP. The Korean company is looking for European partners which introduce synthetic bone graft products to their dental market using its bone graft materials with OCP under the supplier agreement.